Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neoantigen Targeted Therapies industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Gradalis
Vaxon Biotech
Neon Therapeutics
Medigene
Immunicum
Iovance Biotherapeutics
Immunovative Therapies
Precision Biologics
Bavarian Nordic
By Type:
Combination Therapy
Monotherapy
By Application:
Other
Medical Research Institution
Hospital and Clinic
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neoantigen Targeted Therapies Market Overview 2018-2029
-
1.1 China Neoantigen Targeted Therapies Industry Development Overview
-
1.2 China Neoantigen Targeted Therapies Industry Development History
-
1.3 China Neoantigen Targeted Therapies Industry Market Size (2018-2029)
-
1.4 China Neoantigen Targeted Therapies Market Analysis by Type from Production Side
-
1.4.1 China Neoantigen Targeted Therapies Production Volume, Production Value and Growth Rate of Combination Therapy (2018-2029)
-
1.4.2 China Neoantigen Targeted Therapies Production Volume, Production Value and Growth Rate of Monotherapy (2018-2029)
-
1.5 China Neoantigen Targeted Therapies Market Analysis by Application from Consumption End
-
1.5.1 China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.2 China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate of Medical Research Institution (2018-2029)
-
1.5.3 China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate of Hospital and Clinic (2018-2029)
-
1.6 China Neoantigen Targeted Therapies Market Analysis by Region
-
1.6.1 North China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
Chapter 2 China Neoantigen Targeted Therapies Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neoantigen Targeted Therapies Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neoantigen Targeted Therapies Market Status and Competition Analysis in 2023
-
2.2.3 China Neoantigen Targeted Therapies Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neoantigen Targeted Therapies Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neoantigen Targeted Therapies Industry Development
Chapter 3 Neoantigen Targeted TherapiesIndustry Chain Analysis
-
3.1 Neoantigen Targeted Therapies Industry Chain
-
3.2 Neoantigen Targeted Therapies Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neoantigen Targeted Therapies Market
-
3.3 Neoantigen Targeted Therapies Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neoantigen Targeted Therapies Market
Chapter 4 China Neoantigen Targeted Therapies Market, by Type
-
4.1 China Neoantigen Targeted Therapies Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neoantigen Targeted Therapies Total Production Volume and Growth Rate from Production Side
-
4.5 China Neoantigen Targeted Therapies Production Volume and Growth Rate, by Type
-
4.5.1 China Neoantigen Targeted Therapies Production Volume and Growth Rate of Combination Therapy
-
4.5.2 China Neoantigen Targeted Therapies Production Volume and Growth Rate of Monotherapy
Chapter 5 China Neoantigen Targeted Therapies Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neoantigen Targeted Therapies Total Market Size and Growth Rate from Consumption End
-
5.5 China Neoantigen Targeted Therapies Market Size and Growth Rate, by Application
-
5.5.1 China Neoantigen Targeted Therapies Market Size and Growth Rate of Other
-
5.5.2 China Neoantigen Targeted Therapies Market Size and Growth Rate of Medical Research Institution
-
5.5.3 China Neoantigen Targeted Therapies Market Size and Growth Rate of Hospital and Clinic
Chapter 6 China Neoantigen Targeted Therapies Market, by Region
-
6.1 China Neoantigen Targeted Therapies Production Volume and Production Value, by Region
-
6.2 China Neoantigen Targeted Therapies Sales Volume and Sales Value, by Region
Chapter 7 North China Neoantigen Targeted Therapies Market Analysis
-
7.1 North China Neoantigen Targeted Therapies Market, by Type
-
7.2 North China Neoantigen Targeted Therapies Market, by Application
Chapter 8 Central China Neoantigen Targeted Therapies Market Analysis
-
8.1 Central China Neoantigen Targeted Therapies Market, by Type
-
8.2 Central China Neoantigen Targeted Therapies Market, by Application
Chapter 9 South China Neoantigen Targeted Therapies Market Analysis
-
9.1 South China Neoantigen Targeted Therapies Market, by Type
-
9.2 South China Neoantigen Targeted Therapies Market, by Application
Chapter 10 East China Neoantigen Targeted Therapies Market Analysis
-
10.1 East China Neoantigen Targeted Therapies Market, by Type
-
10.2 East China Neoantigen Targeted Therapies Market, by Application
Chapter 11 Northeast China Neoantigen Targeted Therapies Market Analysis
-
11.1 Northeast China Neoantigen Targeted Therapies Market, by Type
-
11.2 Northeast China Neoantigen Targeted Therapies Market, by Application
Chapter 12 Southwest China Neoantigen Targeted Therapies Market Analysis
-
12.1 Southwest China Neoantigen Targeted Therapies Market, by Type
-
12.2 Southwest China Neoantigen Targeted Therapies Market, by Application
Chapter 13 Northwest China Neoantigen Targeted Therapies Market Analysis
-
13.1 Northwest China Neoantigen Targeted Therapies Market, by Type
-
13.2 Northwest China Neoantigen Targeted Therapies Market, by Application
Chapter 14 Company Profiles
-
14.1 Gradalis
-
14.1.1 Gradalis Company Profile
-
14.1.2 Gradalis Neoantigen Targeted Therapies Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Vaxon Biotech
-
14.2.1 Vaxon Biotech Company Profile
-
14.2.2 Vaxon Biotech Neoantigen Targeted Therapies Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Neon Therapeutics
-
14.3.1 Neon Therapeutics Company Profile
-
14.3.2 Neon Therapeutics Neoantigen Targeted Therapies Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Medigene
-
14.4.1 Medigene Company Profile
-
14.4.2 Medigene Neoantigen Targeted Therapies Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Immunicum
-
14.5.1 Immunicum Company Profile
-
14.5.2 Immunicum Neoantigen Targeted Therapies Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Iovance Biotherapeutics
-
14.6.1 Iovance Biotherapeutics Company Profile
-
14.6.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Immunovative Therapies
-
14.7.1 Immunovative Therapies Company Profile
-
14.7.2 Immunovative Therapies Neoantigen Targeted Therapies Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Precision Biologics
-
14.8.1 Precision Biologics Company Profile
-
14.8.2 Precision Biologics Neoantigen Targeted Therapies Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Bavarian Nordic
-
14.9.1 Bavarian Nordic Company Profile
-
14.9.2 Bavarian Nordic Neoantigen Targeted Therapies Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neoantigen Targeted Therapies Industry Research Conclusions
-
15.2 Neoantigen Targeted Therapies Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neoantigen Targeted Therapies Industry Market Size (2018-2029)
-
Figure China Neoantigen Targeted Therapies Production Volume, Production Value and Growth Rate of Combination Therapy (2018-2029)
-
Figure China Neoantigen Targeted Therapies Production Volume, Production Value and Growth Rate of Monotherapy (2018-2029)
-
Figure China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate of Medical Research Institution (2018-2029)
-
Figure China Neoantigen Targeted Therapies Sales Volume, Sales Value and Growth Rate of Hospital and Clinic (2018-2029)
-
Figure North China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure Central China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure South China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure East China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neoantigen Targeted Therapies Market Size and Growth Rate from 2018-2029
-
Figure Neoantigen Targeted Therapies Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neoantigen Targeted Therapies Market Share by Type in 2018
-
Figure China Neoantigen Targeted Therapies Market Share by Type in 2023
-
Figure China Neoantigen Targeted Therapies Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neoantigen Targeted Therapies Production Volume and Growth Rate of Combination Therapy (2018-2023)
-
Figure China Neoantigen Targeted Therapies Production Volume and Growth Rate of Monotherapy (2018-2023)
-
Figure China Neoantigen Targeted Therapies Market Share by Application in 2018
-
Figure China Neoantigen Targeted Therapies Market Share by Application in 2023
-
Figure China Neoantigen Targeted Therapies Total Market Size and Growth Rate from Consumption End
-
Figure China Neoantigen Targeted Therapies Market Size and Growth Rate of Other (2018-2023)
-
Figure China Neoantigen Targeted Therapies Market Size and Growth Rate of Medical Research Institution (2018-2023)
-
Figure China Neoantigen Targeted Therapies Market Size and Growth Rate of Hospital and Clinic (2018-2023)
-
Table China Neoantigen Targeted Therapies Production Volume by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Production Volume Share by Region (2018-2023)
-
Figure China Neoantigen Targeted Therapies Production Volume Share by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Production Value by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Production Value Share by Region (2018-2023)
-
Figure China Neoantigen Targeted Therapies Production Value Share by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Sales Volume by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Sales Volume Share by Region (2018-2023)
-
Figure China Neoantigen Targeted Therapies Sales Volume Share by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Sales Value by Region (2018-2023)
-
Table China Neoantigen Targeted Therapies Sales Value Share by Region (2018-2023)
-
Figure China Neoantigen Targeted Therapies Sales Value Share by Region (2018-2023)
-
Table North China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table North China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure North China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table North China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table North China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure North China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table Central China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table Central China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure Central China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table Central China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table Central China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure Central China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table South China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table South China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure South China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table South China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table South China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure South China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table East China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table East China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure East China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table East China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table East China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure East China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table Northeast China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table Northeast China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table Northeast China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table Southwest China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table Southwest China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table Southwest China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neoantigen Targeted Therapies Production Volume by Type (2018-2023)
-
Table Northwest China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neoantigen Targeted Therapies Production Volume Share by Type (2018-2023)
-
Table Northwest China Neoantigen Targeted Therapies Sales Volume by Application (2018-2023)
-
Table Northwest China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neoantigen Targeted Therapies Sales Volume Share by Application (2018-2023)
-
Table Gradalis Company Profile
-
Table Gradalis Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Vaxon Biotech Company Profile
-
Table Vaxon Biotech Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Neon Therapeutics Company Profile
-
Table Neon Therapeutics Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Medigene Company Profile
-
Table Medigene Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Immunicum Company Profile
-
Table Immunicum Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Iovance Biotherapeutics Company Profile
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Immunovative Therapies Company Profile
-
Table Immunovative Therapies Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Precision Biologics Company Profile
-
Table Precision Biologics Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
Table Bavarian Nordic Company Profile
-
Table Bavarian Nordic Neoantigen Targeted Therapies Revenue, Price and Gross (2018-2023)
-
